In a report released today, David Saxon from Needham maintained a Hold rating on ZimVie Inc (ZIMV – Research Report). The company’s shares closed yesterday at $19.05.
Saxon covers the Healthcare sector, focusing on stocks such as RxSight, Alphatec Holdings, and Azenta. According to TipRanks, Saxon has an average return of 6.5% and a 47.27% success rate on recommended stocks.
ZimVie Inc has an analyst consensus of Moderate Sell, with a price target consensus of $14.50.
See the top stocks recommended by analysts >>
The company has a one-year high of $20.44 and a one-year low of $5.05. Currently, ZimVie Inc has an average volume of 334.1K.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
ZimVie Inc (ZIMV) Company Description:
ZimVie Inc is focused on the dental and spine markets and their respective growth drivers such as implants, surgical tools, bone graft substitutes, spinal fusion implants, non-fusion alternatives, and digital care management solutions.
Read More on ZIMV:
